Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Shares Issued: 2018-2024

Historic Shares Issued for Avidity Biosciences (RNA) over the last 7 years, with Dec 2024 value amounting to $762.2 million.

  • Avidity Biosciences' Shares Issued rose 156.89% to $831.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $836.9 million, marking a year-over-year increase of 4.51%. This contributed to the annual value of $762.2 million for FY2024, which is 1158.79% up from last year.
  • Per Avidity Biosciences' latest filing, its Shares Issued stood at $762.2 million for FY2024, which was up 1,158.79% from $60.5 million recorded in FY2023.
  • In the past 5 years, Avidity Biosciences' Shares Issued ranged from a high of $762.2 million in FY2024 and a low of $60.5 million during FY2023.
  • Over the past 3 years, Avidity Biosciences' median Shares Issued value was $344.8 million (recorded in 2022), while the average stood at $389.2 million.
  • Its Shares Issued has fluctuated over the past 5 years, first surged by 421,521.54% in 2020, then plummeted by 82.44% in 2023.
  • Yearly analysis of 5 years shows Avidity Biosciences' Shares Issued stood at $274.1 million in 2020, then plummeted by 36.26% to $174.7 million in 2021, then spiked by 97.38% to $344.8 million in 2022, then crashed by 82.44% to $60.5 million in 2023, then surged by 1,158.79% to $762.2 million in 2024.